VentriPoint Historical Balance Sheet

VPT Stock  CAD 0.11  0.01  8.33%   
Trend analysis of VentriPoint Diagnostics balance sheet accounts such as Total Assets of 2 M, Total Current Liabilities of 2.1 M, Total Stockholder Equity of 199.2 K or Accounts Payable of 792.1 K provides information on VentriPoint Diagnostics' total assets, liabilities, and equity, which is the actual value of VentriPoint Diagnostics to its prevalent stockholders. By breaking down trends over time using VentriPoint Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining VentriPoint Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether VentriPoint Diagnostics is a good buy for the upcoming year.

VentriPoint Diagnostics Inventory

0.0

  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About VentriPoint Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of VentriPoint Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. VentriPoint Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of VentriPoint Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which VentriPoint currently owns. An asset can also be divided into two categories, current and non-current.

VentriPoint Diagnostics Balance Sheet Chart

At this time, VentriPoint Diagnostics' Total Current Assets are fairly stable compared to the past year. Non Current Liabilities Total is likely to climb to about 468.6 K in 2024, despite the fact that Retained Earnings are likely to grow to (50.8 M).

Total Assets

Total assets refers to the total amount of VentriPoint Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in VentriPoint Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on VentriPoint Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of VentriPoint Diagnostics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents VentriPoint Diagnostics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of VentriPoint Diagnostics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of VentriPoint Diagnostics balance sheet. This account contains VentriPoint Diagnostics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by VentriPoint Diagnostics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Liabilities And Stockholders Equity

The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.
Most accounts from VentriPoint Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, VentriPoint Diagnostics' Total Current Assets are fairly stable compared to the past year. Non Current Liabilities Total is likely to climb to about 468.6 K in 2024, despite the fact that Retained Earnings are likely to grow to (50.8 M).
 2021 2022 2023 2024 (projected)
Total Current Liabilities1.1M1.1M1.4M2.1M
Total Assets9.5M6.0M1.9M2.0M

VentriPoint Diagnostics balance sheet Correlations

-0.310.93-0.97-0.390.21.01.00.470.560.36-0.321.00.01-0.160.220.190.380.26-0.48-0.29-0.490.29-0.13-0.48-0.23
-0.31-0.620.450.150.24-0.34-0.34-0.09-0.440.250.93-0.310.10.31-0.39-0.4-0.41-0.280.540.620.420.11-0.320.010.27
0.93-0.62-0.97-0.390.040.930.930.410.630.15-0.650.93-0.08-0.380.310.270.460.33-0.67-0.42-0.530.190.08-0.45-0.21
-0.970.45-0.970.39-0.11-0.97-0.97-0.37-0.58-0.20.5-0.970.010.37-0.2-0.17-0.43-0.340.620.290.51-0.27-0.060.460.16
-0.390.15-0.390.39-0.69-0.36-0.36-0.66-0.88-0.210.13-0.370.510.03-0.53-0.38-0.89-0.770.560.60.82-0.540.20.750.07
0.20.240.04-0.11-0.690.170.170.370.40.370.30.19-0.050.280.07-0.010.540.55-0.14-0.52-0.540.59-0.44-0.52-0.04
1.0-0.340.93-0.97-0.360.171.00.410.540.3-0.351.00.04-0.180.180.140.370.25-0.49-0.29-0.480.26-0.09-0.44-0.24
1.0-0.340.93-0.97-0.360.171.00.410.540.3-0.351.00.03-0.180.180.150.370.25-0.49-0.29-0.480.26-0.09-0.44-0.24
0.47-0.090.41-0.37-0.660.370.410.410.780.6-0.020.45-0.510.140.730.620.530.3-0.38-0.34-0.560.35-0.5-0.7-0.17
0.56-0.440.63-0.58-0.880.40.540.540.780.27-0.380.55-0.63-0.070.750.580.890.64-0.67-0.59-0.870.4-0.22-0.71-0.21
0.360.250.15-0.2-0.210.370.30.30.60.270.350.34-0.120.380.330.330.07-0.070.05-0.04-0.250.53-0.44-0.36-0.25
-0.320.93-0.650.50.130.3-0.35-0.35-0.02-0.380.35-0.320.080.63-0.27-0.3-0.35-0.320.680.470.310.11-0.490.10.06
1.0-0.310.93-0.97-0.370.191.01.00.450.550.34-0.320.02-0.170.20.160.360.25-0.48-0.28-0.470.28-0.13-0.47-0.23
0.010.1-0.080.010.51-0.050.040.03-0.51-0.63-0.120.080.020.02-0.61-0.29-0.5-0.120.450.140.45-0.030.10.470.14
-0.160.31-0.380.370.030.28-0.18-0.180.14-0.070.380.63-0.170.020.130.07-0.04-0.230.64-0.11-0.080.04-0.60.25-0.43
0.22-0.390.31-0.2-0.530.070.180.180.730.750.33-0.270.2-0.610.130.910.580.27-0.41-0.35-0.610.21-0.2-0.43-0.21
0.19-0.40.27-0.17-0.38-0.010.140.150.620.580.33-0.30.16-0.290.070.910.420.3-0.3-0.27-0.450.25-0.12-0.3-0.11
0.38-0.410.46-0.43-0.890.540.370.370.530.890.07-0.350.36-0.5-0.040.580.420.83-0.6-0.65-0.90.56-0.08-0.47-0.14
0.26-0.280.33-0.34-0.770.550.250.250.30.64-0.07-0.320.25-0.12-0.230.270.30.83-0.5-0.51-0.70.650.01-0.370.21
-0.480.54-0.670.620.56-0.14-0.49-0.49-0.38-0.670.050.68-0.480.450.64-0.41-0.3-0.6-0.50.370.63-0.22-0.270.59-0.12
-0.290.62-0.420.290.6-0.52-0.29-0.29-0.34-0.59-0.040.47-0.280.14-0.11-0.35-0.27-0.65-0.510.370.63-0.230.10.330.26
-0.490.42-0.530.510.82-0.54-0.48-0.48-0.56-0.87-0.250.31-0.470.45-0.08-0.61-0.45-0.9-0.70.630.63-0.520.140.50.19
0.290.110.19-0.27-0.540.590.260.260.350.40.530.110.28-0.030.040.210.250.560.65-0.22-0.23-0.52-0.01-0.210.15
-0.13-0.320.08-0.060.2-0.44-0.09-0.09-0.5-0.22-0.44-0.49-0.130.1-0.6-0.2-0.12-0.080.01-0.270.10.14-0.010.320.14
-0.480.01-0.450.460.75-0.52-0.44-0.44-0.7-0.71-0.360.1-0.470.470.25-0.43-0.3-0.47-0.370.590.330.5-0.210.32-0.01
-0.230.27-0.210.160.07-0.04-0.24-0.24-0.17-0.21-0.250.06-0.230.14-0.43-0.21-0.11-0.140.21-0.120.260.190.150.14-0.01
Click cells to compare fundamentals

VentriPoint Diagnostics Account Relationship Matchups

VentriPoint Diagnostics balance sheet Accounts

201920202021202220232024 (projected)
Total Assets314.3K801.6K9.5M6.0M1.9M2.0M
Total Current Liabilities1.9M1.8M1.1M1.1M1.4M2.1M
Total Stockholder Equity(2.5M)(2.3M)8.3M4.6M189.7K199.2K
Net Debt1.1M843.8K(9.1M)(4.7M)(1.0M)(969.0K)
Retained Earnings(37.9M)(39.9M)(43.7M)(48.6M)(53.5M)(50.8M)
Accounts Payable1.2M1.0M988.6K842.0K856.2K792.2K
Cash13.8K526.0K9.3M5.2M1.3M1.5M
Cash And Short Term Investments13.8K526.0K9.3M5.2M1.3M1.5M
Net Receivables67.7K165.3K197.5K374.2K285.5K299.8K
Common Stock Shares Outstanding63.4M74.5M136.1M156.0M156.8M164.7M
Liabilities And Stockholders Equity314.3K801.6K9.5M6.0M1.9M2.0M
Other Stockholder Equity6.0M6.4M9.8M10.4M10.9M7.5M
Total Liab2.8M3.2M1.2M1.4M1.7M2.6M
Total Current Assets176.0K714.5K9.5M5.7M1.6M1.9M
Non Current Liabilities Total868.0K1.3M125.4K367.4K297.0K468.6K
Property Plant And Equipment Net138.3K87.1K42.5K313.3K246.6K258.9K
Non Current Assets Total138.3K87.1K42.5K313.3K246.6K134.6K
Other Current Liab12.8K500.062.3K122.1K453.6K753.2K
Short Term Debt257.1K42.8K34.6K91.6K55.0K52.3K
Net Tangible Assets(1.7M)(1.0M)(2.5M)(2.3M)(2.1M)(2.2M)
Other Current Assets63.8K23.1K35.9K103.5K56.9K73.8K
Common Stock29.5M31.0M42.2M42.7M49.1M28.8M
Property Plant Equipment49.9K49.0K138.3K87.1K100.1K71.6K
Net Invested Capital(1.5M)(1.1M)8.5M4.7M327.8K311.4K
Net Working Capital(1.7M)(1.1M)8.4M4.6M240.1K228.1K
Capital Stock29.5M31.0M42.2M42.7M49.1M39.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.